Please ensure Javascript is enabled for purposes of website accessibility

Eli Lilly Will Provide Drive-Through Coronavirus Testing to Indianapolis Healthcare Workers

By Prosper Junior Bakiny - Mar 22, 2020 at 9:26PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company continues to help its home state fight COVID-19.

With COVID-19 still spreading rapidly across the country, most states in the U.S. have taken drastic measures -- such as closing down public schools and places of businesses, and encouraging people to practice social distancing -- to try to "flatten the curve." However, many of those in the healthcare field are at the front lines of this pandemic, and they don't have the luxury to suspend their day-to-day activities. Also, because of their constant interactions with COVID-19 patients, many healthcare workers are at a much higher risk than the average person to contract the disease.

In that spirit, Eli Lilly (LLY 4.12%) recently announced it would provide drive-through testing for the SARS-CoV-2 virus -- the virus that causes COVID-19 -- to healthcare workers in  Indianapolis, where it is based. This initiative will start on Monday, March 23, and will be available free of charge only to active healthcare workers, including doctors, nurses, and pharmacists.

Covid-19 written on a face mask.

Image source: Getty Images.

Eli Lilly has lent its resources to help fight COVID-19 in its home state before. On March 18, the pharma giant announced that it would partner with the Indiana State Department of Health, with backing from the U.S. Food and Drug Administration, to speed up the process to test for COVID-19 in Indiana. While we can no longer stop the spread of COVID-19, expanding access to tests for the potentially deadly disease is critical to slowing down its spread, which makes Eli Lilly's recent moves particularly noteworthy. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Eli Lilly and Company Stock Quote
Eli Lilly and Company
$325.62 (4.12%) $12.90

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.